Tablets
-
Subject Areas on Research
- "Take your pill": the role and fantasy of pills in modern medicine.
- A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
- A new objective measurement of esophageal lumen patency.
- A randomized, crossover phase 1 study to assess the effects of formulation (capsule vs tablet) and meal consumption on the bioavailability of dovitinib (TKI258).
- Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone.
- Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.
- Comparison of Glucosamine Absorption After Administration of Oral Liquid, Chewable, and Tablet Formulations to Dogs.
- Determination of sulfadiazine and sulfamethoxazole by capillary electrophoresis with end-column electrochemical detection.
- Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
- Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.
- Evaluation of a sol-gel derived carbon composite electrode as an amperometric detector for capillary electrophoresis.
- Everolimus tablets for patients with subependymal giant cell astrocytoma.
- Multiple dose pharmacokinetics of four different doses of nisoldipine in hypertensive patients.
- Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge.
- Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery.
- Oral ondansetron pharmacokinetics: the effect of chemotherapy.
- PA tablets: investigational compounds combining aspirin and omeprazole for cardioprotection.
- Pharmacobezoar in a patient on an oral phosphate binder.
- Pharmacokinetics of oral treprostinil sustained release tablets during chronic administration to patients with pulmonary arterial hypertension.
- Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.
- Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas.
- Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass.
- Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.
- The determination of thyroxine with special reference to tablets.